QI
AMED

QS Investors’s Amedisys AMED Stock Holding History

QS Investors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,174
Closed -$6.8M – 1183
2020
Q4 		$6.8M Hold
23,174
– – 0.08% 177
2020
Q3 		$5.48M Sell
23,174
-27,294
-54% -$6.21M 0.07% 188
2020
Q2 		$10M Buy
50,468
+9,800
+24% +$1.83M 0.14% 133
2020
Q1 		$7.46M Sell
40,668
-6,035
-13% -$1.07M 0.12% 146
2019
Q4 		$7.76M Sell
46,703
-4,800
-9% -$714K 0.08% 189
2019
Q3 		$6.75M Sell
51,503
-1,779
-3% -$232K 0.07% 204
2019
Q2 		$6.47M Sell
53,282
-10,890
-17% -$1.29M 0.07% 202
2019
Q1 		$7.91M Buy
64,172
+12,514
+24% +$1.57M 0.09% 152
2018
Q4 		$6.05M Buy
51,658
+19,339
+60% +$2.28M 0.08% 172
2018
Q3 		$4.04M Buy
32,319
+30,519
+1,696% +$3.37M 0.04% 356
2018
Q2 		$154K Buy
+1,800
New +$132K ﹤0.01% 1289
2016
Q4 		– Sell
-52,800
Closed -$2.5M – 1923
2016
Q3 		$2.5M Sell
52,800
-27,600
-34% -$1.38M 0.02% 594
2016
Q2 		$4.06M Hold
80,400
– – 0.03% 453
2016
Q1 		$3.89M Sell
80,400
-15,400
-16% -$594K 0.04% 473
2015
Q4 		$3.77M Sell
95,800
-44,300
-32% -$1.77M 0.04% 484
2015
Q3 		$5.32M Buy
140,100
+112,500
+408% +$4.74M 0.06% 335
2015
Q2 		$1.1M Buy
+27,600
New +$860K 0.01% 737

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

QS Investors's AMED Position: Q1 2021 in Review

QS Investors sold out of Amedisys (AMED) in Q1 2021, closing a stake of 23,174 shares — an estimated $6.8M sold.

QS Investors first reported a position in AMED in Q2 2015 and held it in 17 quarters. The position peaked at $10M in Q2 2020. 389 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • QS Investors reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • QS Investors sold 23,174 Amedisys shares in Q1 2021, an estimated $6.8M.
  • QS Investors first reported a position in Amedisys in Q2 2015 and held it in 17 quarters.
  • QS Investors's Amedisys position peaked at $10M in Q2 2020.
  • 389 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.